Danuta CZERNOMYSY-FUROWICZ, Karol FIJALKOWSKI, Anna SILECKA, Jolanta KARAKULSKA

Herd-specific autovaccine and antibiotic treatment in elimination of Staphylococcus aureus mastitis in dairy cattle

The aim of the present study was to compare the effectiveness of cefuroxime, herd-specific autovaccine, and cefuroxime/herd-specific autovaccine treatments in eliminating S. aureus from the milk of 45 cows with subclinical mastitis. Prior to this study, cows with S. aureus mastitis were divided into 3 groups of 15 cows each. Group 1 received cefuroxime, group 2 received the autovaccine, and group 3 received cefuroxime and the autovaccine. The antibiotic was infused into the teat canal, whereas the autovaccine was administrated in the upper udder lymph node region. It was revealed that after day 35 of the treatment S. aureus was not detected in the milk of 40% of the cows treated with antibiotic, 60% of the cows treated with the autovaccine, and 100% of the cows that underwent combined therapy. Further observation of cows selected for the current study showed that in cows treated with both cefuroxime and a herd-specific autovaccine S. aureus mastitis was not recorded for at least 2 years. In conclusion, this investigation revealed that the administration of an anti-S. aureus herd-specific autovaccine into the upper udder lymph node region combined with infusion of an appropriate antibiotic into the teat canal eliminates S. aureus and leads to prolonged udder protection against invasion by these microorganisms.

Anahtar Kelimeler:

S. aureus, autovaccine, antibiotic, mastitis, cattle

Herd-specific autovaccine and antibiotic treatment in elimination of Staphylococcus aureus mastitis in dairy cattle

Keywords:

S. aureus, autovaccine, antibiotic, mastitis, cattle,

PDF

___

Nour El-Din AN, Shkreta L, Talbot BG, Diarra MS, Lacasse P.
DNA immunization of dairy cows with the clumping factor A
of Staphylococcus aureus. Vaccine 2006; 24: 1997–2006. 5.
Perez-Casal J, Prysliak T, Kerro-Dego O, Potter AA. Immune
responses to a Staphylococcus aureus GapC/B chimera and its
potential use as a component of a vaccine for S. aureus mastitis.
Vet Immunol Immunopathol 2006; 109: 85–97. 6.
Middleton J, Luby CD, Adams DS. Efficacy of vaccination
against staphylococcal mastitis: a review and new data. Vet
Nolte O, Morscher J, Weiss H, Sonntag H. Autovaccination of dairy cows to treat post partum metritis caused by Actinomyces pyogenes. Vaccine 2001; 19: 3146–3153.
Hałasa J. Zasadność stosowania autoszczepionek. Med Dosw Mikrobiol 1994; 46: 5–9 (in Polish).
Meulemans L, Hermans K, Lipinska U, Duchateau L, Haesebrouck F. Possible protective effect of an autovaccine against high virulence Staphylococcus aureus in a rabbit skin infection model. In: Proceedings of the 9th World Rabbit Congress. Verona, Italy; WRC; 2008. pp 1019–1023.
Aarestrup FM, Scott NL, Sordillo LM. Ability of Staphylococcus aureus coagulase genotypes to resist neutrophil bactericidal activity and phagocytosis. Infect Immun 1994; 62: 5679–5682.
Aarestrup FM, Dangler CA, Sordillo LM. Prevalence of coagulase gene polymorphism in Staphylococcus aureus isolates causing bovine mastitis. Can J Vet Res 1995; 59: 124–128.
Reinoso E, Bettera S, Frigerio C, DiRenzo M, Calzolari A, Bogni C. RAPD-PCR analysis of Staphylococcus aureus strains isolated from bovine and human hosts. Microbiol Res 2004; 159: 245–255.
Nawrotek P, Karakulska J, Czernomysy-Furowicz D, Borkowski J, Furowicz AJ. Typowanie molekularne szczepów Staphylococcus aureus wyizolowanych z mleka krów chorych na mastitis. Med. Weter. 2009; 65: 127–130 (in Polish).
CLSI, 2002. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals; Approved Standard. 2nd ed. NCCLS document M31-A2. Wayne, PA, USA.
Gold B, Rodriguez WJ. Cefuroxime: mechanisms of action, antimicrobial activity, pharmacokinetics, clinical applications, adverse reactions and therapeutic indications. Pharmacotherapy 1983; 3: 82–100.
Leitner G, Yadlin B, Glickman A, Chaffer M, Saran A. Systemic and local immune response of cows to intramammary infection with Staphylococcus aureus. Res Vet Sci 2000; 69: 181–184.
Nansen P. Selective immunoglobulin deficiency in cattle and susceptibility to infection. Acta. Pathol. Microbiol. Scand Section B Microbiol Immunol 1972; 80: 49–54.
Mackie DP, Logan EF. Changes in immunoglobulin levels in whey during experimental Streptococcus agalactiae mastitis. Res Vet Sci 1986; 40: 183–188.
Caffin JP, Poutrel B. Physiological and pathological factors influencing bovine immunoglobulin G2 concentration in milk. J Dairy Sci 1988; 71: 2035–2043.
Riollet C, Rainard P, Poutrel B. Kinetics of cells and cytokines during immune-mediated inflammation in the mammary gland of cows systemically immunized with Staphylococcus aureus α-toxin. Inflamm Res 2000; 49: 486–496.
Paape M, Mehrzad J, Zhao X, Detilleux J, Burvenich C. Defense of the bovine mammary gland by polymorphonuclear neutrophil leukocytes. J Mam Gland Biol Neoplasia 2002; 7: 109–121.
Sordillo LM, Streicher KL. Mammary gland immunity and mastitis susceptibility. J Mam Gland Biol Neoplasia 2002; 7: 135–146.
Rainard P, Riollet C. Innate immunity of the bovine mammary gland. Vet Res 2006; 37: 369–400.
Heyneman R, Burvenich C, Vercauteren R. Interaction between the respiratory burst activity of neutrophil leukocytes and experimentally induced Escherichia coli mastitis in cow. J Dairy Sci 1990; 73: 985–994.
Takacova J, Kotulova D, Kasickova A, Ferencik M. The effect of Staphylococcus aureus vaccine on professional phagocytes in vitro and in vivo. Bratisl Med J 1993; 94: 444–448.
Kasprowicz AK. Bakteryjne czynniki etiologiczne u chorych kierowanych do leczenia autoszczepionką. Med Dosw Mikrobiol 1994; 46: 17–26 (in Polish).
Fijałkowski K, Czernomysy-Furowicz D, Irwin JA, Nawrotek P, Pobucewicz A. Secretory virulence factors produced by Staphylococcus aureus isolates obtained from mastitic bovine milk – effect on bovine polymorphonuclear neutrophils. Res Vet Sci 2011; 93: 82–87.
Smith GW, Lyman RL, Anderson KL. Efficacy of vaccination and antimicrobial treatment to eliminate chronic intramammary Staphylococcus aureus infections in dairy cattle. J Am Vet Med Assoc 2006; 228: 422–425.